Global Exosome Diagnostics and Therapeutic Market to Register A Growth Rate of Over 32% Through 2027

June 26, 2020


As per the report titled ‘Exosome Diagnostics and Treatment Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Product; Service; Application; & End User, available with Market Study Report LLC, global exosome diagnostics and therapeutic market is expected to reach USD 358.91 million, registering an exceptionally high CAGR of 32.2% through 2027.
 

Factors like greater accuracy, benefits over traditional methods, and increasing R & D of exosomes are augmenting the growth of global exosome diagnostics and therapeutic market. However, under-developed infrastructure, and unavailability of skilled professionals may act as a restraint to the expansion of the market to some extent, claim market analysts.
 

Exosomes are released into extracellular spaces by majority of the cells, eventually getting accumulated in the body fluid circulation. Exosomes behave like messengers, passing information between different cell types. Numerous healthcare organizations and industry players are working on methods to boost the development of exosome applications; adding momentum to the market expansion.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/2623841/
 

Global exosome diagnostics and therapeutic market is bifurcated based on application segment, product terrain, and end-user spectrum.
 

Based on application segment, the market is classified in terms of therapeutic applications and diagnostics applications. The latter segment accounted for the largest market share in 2019 and is anticipated to register a notable CAGR during the analysis timeframe.
 

Based on product terrain, the instruments segment held the largest fragment of the market in 2019, however, the software segment is slated to record the highest CAGR during the study period.
 

Based on end-user spectrum, the market is divided into cancer institute, hospitals, diagnostics centers, and others. Among these, cancer institute segment dominated the market share in 2019 and is anticipated to expand substantially, recording the a high CAGR.
 

Major companies operating in global exosome diagnostics and therapeutic market are Cell Guidance Systems, Evomic Science LLC, Miltenyi Biotec, Aethlon Medical, Inc, ITH, Immune Therapy Holdings AB, Bioregenerative Sciences, Norgen Biotek Corp, Therapeutic Solutions International, Inc., RENEURON GROUP PLC, and Exosome Diagnostics among others.

Chat with us